Figure 9: Evolutions of TFP Growth Rates for Selective Economies as a Function of their Relative Per Capita GDP to the US
Figure 5: The US Pharmacy Distribution and Reimbursement System for Patient-Administered, Outpatient Brand-Name Drugs
Figure 6: Pharmaceutical Manufacturers’ Off-Invoice Discounts, Rebates, and Price Concessions, 2008-2022
Figure 7: Growth in List and Net Prices Per Treatment Course or Annual Treatment Supply in Select Categories (2012-2017)
Figure 8: Type of Cost Sharing for Prescription Drug Benefits, Employer-Sponsored Plans Without High Deductibles, by Benefit Tier, 2022